{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T21:28:56Z","timestamp":1785274136193,"version":"3.55.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.mehy.2020.110394","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T11:42:04Z","timestamp":1605181324000},"page":"110394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19"],"prefix":"10.1016","volume":"146","author":[{"given":"Xiyuan","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Hippensteel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alida","family":"Leavitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Beckham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Freed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Ordway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Sandhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward D.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.110394_b0005","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.110394_b0010","article-title":"Dexamethasone in the management of covid-19: Preliminary trial results are mostly good news, but timing is everything","author":"Johnson","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.mehy.2020.110394_b0015","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2002032","article-title":"China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2020.110394_b0020","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ajem.2020.04.048","article-title":"Cardiovascular complications in COVID-19","volume":"38","author":"Long","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.mehy.2020.110394_b0025","doi-asserted-by":"crossref","unstructured":"Middleton EA, He X-Y, Denorme F, et al. Neutrophil Extracellular Traps (NETs) Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome. Blood 2020; Online ahead of print.","DOI":"10.1182\/blood.2020007008"},{"key":"10.1016\/j.mehy.2020.110394_b0030","doi-asserted-by":"crossref","DOI":"10.1111\/jth.14828","article-title":"Tissue Plasminogen Activator (tPA) Treatment for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series","author":"Wang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.mehy.2020.110394_b0035","doi-asserted-by":"crossref","unstructured":"Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents 2020; [Epub ahead of print].","DOI":"10.1016\/j.ijantimicag.2020.105954"},{"key":"10.1016\/j.mehy.2020.110394_b0040","unstructured":"NIAID-RML. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. 2020. Available from: https:\/\/www.covid19treatmentguidelines.nih.gov\/."},{"key":"10.1016\/j.mehy.2020.110394_b0045","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2001282","article-title":"A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2020.110394_b0050","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","article-title":"Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19","volume":"382","author":"Geleris","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2020.110394_b0055","first-page":"E-pub","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.110394_b0060","unstructured":"Beigel JH, Tomashek KM, Dodd LE, et al. ACTT-1 Study Group Members. Remdesivir for the Treatment of Covid-19 - Preliminary Report. N Engl J Med 2020; Online ahead of print."},{"key":"10.1016\/j.mehy.2020.110394_b0065","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.110394_b0070","article-title":"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA","author":"Wu","year":"2020","journal-title":"Intern Med"},{"key":"10.1016\/j.mehy.2020.110394_b0075","doi-asserted-by":"crossref","unstructured":"McGonagle D, Sharif K, O'Regan A, Bridgewood C. The Role of Cytokines Including Interleukin-6 in COVID-19 Induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmun Rev 2020; Online ahead of print.","DOI":"10.1016\/j.autrev.2020.102537"},{"key":"10.1016\/j.mehy.2020.110394_b0080","unstructured":"Horby PW, Landry MJ. RECOVERY Collaborative Group. Effect of dexamethasone in hospitalized patients with COVID-19 - Preliminary Report. medRxiv preprint 2020."},{"key":"10.1016\/j.mehy.2020.110394_b0085","unstructured":"Sterne JAC, Murthy S, Diaz JV, et al. WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA Cardiol 2020; Online ahead of print."},{"key":"10.1016\/j.mehy.2020.110394_b0090","unstructured":"Angus DC, Derde L, Al-Beidh F, et al. Writing Committee for the REMAP-CAP Investigators. Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA 2020; Online ahead of print."},{"key":"10.1016\/j.mehy.2020.110394_b0095","article-title":"Tocilizumab for treatment of mechanically ventilated patients with COVID-19","author":"Somers","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mehy.2020.110394_b0100","doi-asserted-by":"crossref","unstructured":"Lipworth BJ, Chan R, Kuo CR. Tocilizumab for severe COVID-19 pneumonia. Lancet Rheumatol 2020; published online ahead of print.","DOI":"10.1016\/S2665-9913(20)30283-6"},{"key":"10.1016\/j.mehy.2020.110394_b0105","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1034\/j.1399-0004.2003.00143.x","article-title":"Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia\/New Zealand: Australia, Canada, New Zealand and the United States of America","volume":"64","author":"de Serres","year":"2003","journal-title":"Clin Genet"},{"key":"10.1016\/j.mehy.2020.110394_b0110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mrrev.2017.03.001","article-title":"Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions","volume":"773","author":"Hazari","year":"2017","journal-title":"Mutat Res"},{"key":"10.1016\/j.mehy.2020.110394_b0115","first-page":"E-pub","article-title":"Geographical overlap between alpha-1 antitrypsin deficiency and COVID-19 infection in Italy: Casual or causal?","author":"Vianello","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.mehy.2020.110394_b0120","doi-asserted-by":"crossref","first-page":"27258","DOI":"10.1016\/S0021-9258(19)61505-X","article-title":"Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity","volume":"275","author":"Taggart","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2020.110394_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2020.04.009","article-title":"An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients","author":"Wang","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.mehy.2020.110394_b0130","doi-asserted-by":"crossref","unstructured":"Harbig A, Mernberger M, Bittel L, et al. Transcriptome profiling and protease inhibition experiments identify proteases that activate H3N2 influenza A and influenza B viruses in murine airway. J Biol Chem 2020; Online ahead of print.","DOI":"10.1096\/fasebj.2021.35.S1.02714"},{"key":"10.1016\/j.mehy.2020.110394_b0135","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12866-016-0751-2","article-title":"Alpha-1-antitrypsin interacts with gp41 to block HIV-1 entry into CD4+ T lymphocytes","volume":"16","author":"Zhou","year":"2016","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.mehy.2020.110394_b0140","doi-asserted-by":"crossref","first-page":"E384","DOI":"10.25011\/cim.v33i6.14589","article-title":"HIV infection is associated with reduced serum alpha-1-antitrypsin concentrations","volume":"33","author":"Bryan","year":"2010","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.mehy.2020.110394_b0145","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.4049\/jimmunol.1001358","article-title":"HIV replication in CD4+ T lymphocytes in the presence and absence of follicular dendritic cells: inhibition of replication mediated by \u03b1-1-antitrypsin through altered I\u03baB\u03b1 ubiquitination","volume":"186","author":"Zhou","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2020.110394_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018589","article-title":"Serpin induced antiviral activity of prostaglandin synthetase-2 against HIV-1 replication","volume":"6","author":"Whitney","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2020.110394_b0155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1096\/fj.00-0311com","article-title":"Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1","volume":"15","author":"Shapiro","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.mehy.2020.110394_b0160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fpubh.2013.00019","article-title":"Alpha-1 antitrypsin reduces severity of pseudomonas pneumonia in mice and inhibits epithelial barrier disruption and pseudomonas invasion of respiratory epithelial cells","volume":"1","author":"Pott","year":"2013","journal-title":"Front Public Health"},{"key":"10.1016\/j.mehy.2020.110394_b0165","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3389\/fimmu.2019.01417","article-title":"Alpha-1-antitrypsin enhances primary human macrophage immunity against non-tuberculous mycobacteria","volume":"10","author":"Bai","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.mehy.2020.110394_b0170","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.1038\/s41467-019-13659-4","article-title":"SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection","volume":"10","author":"Gassen","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.mehy.2020.110394_b0175","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/JVI.02202-13","article-title":"TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein","volume":"88","author":"Heurich","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2020.110394_b0180","doi-asserted-by":"crossref","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 2020; E-pub: pii: S0092-8674(0020)30229-30224.","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"10.1016\/j.mehy.2020.110394_b0185","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/JVI.00094-12","article-title":"Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry","volume":"86","author":"Kawase","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2020.110394_b0190","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1073\/pnas.2002589117","article-title":"Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells","volume":"117","author":"Matsuyama","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mehy.2020.110394_b0195","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pupt.2015.07.001","article-title":"The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells","volume":"33","author":"Yamaya","year":"2015","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.mehy.2020.110394_b0200","doi-asserted-by":"crossref","unstructured":"Azouz NP, Klingler AM, Rothenberg ME. Alpha 1 antitrypsin is an inhibitor of the SARS-CoV2-priming protease TMPRSS2. bioRxiv 2020; Pre-print.","DOI":"10.1101\/2020.05.04.077826"},{"key":"10.1016\/j.mehy.2020.110394_b0205","first-page":"pre-print","article-title":"Alpha-1 antitrypsin inhibits SARS-CoV-2 infection","author":"Wettstein","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.mehy.2020.110394_b0210","unstructured":"Oguntuyo KY, Stevens CS, Siddiquey MN, et al. In plain sight: the role of alpha-1-antitrypsin in COVID-19 pathogenesis and therapeutics. bioRxiv 2020; Preprint."},{"key":"10.1016\/j.mehy.2020.110394_b0215","article-title":"Alpha-1-antitrypsin: A possible host protective factor against Covid-19","volume":"26","author":"de Loyola","year":"2020","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.mehy.2020.110394_b0220","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.antiviral.2009.12.001","article-title":"TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds","volume":"85","author":"Haga","year":"2010","journal-title":"Antiviral Res"},{"key":"10.1016\/j.mehy.2020.110394_b0225","unstructured":"Ellinghaus D, Degenhardt F, Bujanda L, et al. Severe Covid-19 GWAS Group. Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med 2020; Online ahead of print."},{"key":"10.1016\/j.mehy.2020.110394_b0230","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1172\/JCI41196","article-title":"\u03b1-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8","volume":"120","author":"Bergin","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2020.110394_b0235","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1189\/jlb.0212071","article-title":"Alpha-1-antitrypsin inhibits nitric oxide production","volume":"92","author":"Chan","year":"2012","journal-title":"J Leuk Biol"},{"key":"10.1016\/j.mehy.2020.110394_b0240","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1189\/jlb.0208145","article-title":"Alpha-1-antitrypsin is an endogenous inhibitor of pro-inflammatory cytokine production in whole blood","volume":"85","author":"Pott","year":"2009","journal-title":"J Leuk Biol"},{"key":"10.1016\/j.mehy.2020.110394_b0245","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1515\/hsz-2014-0161","article-title":"Immune-modulating effects of alpha-1 antitrypsin","volume":"395","author":"Ehlers","year":"2014","journal-title":"Biol Chem"},{"key":"10.1016\/j.mehy.2020.110394_b0250","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1002\/ijc.24748","article-title":"Akt-mediated regulation of NFkB and the essentialness of NFkB for the oncogenicity of PI3K and Akt","volume":"125","author":"Bai","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.mehy.2020.110394_b0255","doi-asserted-by":"crossref","unstructured":"Lu Y, Sun K, Guo S, et al. Early Warning Indicators of Severe COVID-19: A Single-Center Study of Cases From Shanghai, China. Front Med; 7: 432.","DOI":"10.3389\/fmed.2020.00432"},{"key":"10.1016\/j.mehy.2020.110394_b0260","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0014-5793(92)80156-B","article-title":"Inhibition of neutrophil superoxide production by human plasma alpha 1-antitrypsin","volume":"300","author":"Bucurenci","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1016\/j.mehy.2020.110394_b0265","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/sj.jhh.1002101","article-title":"Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade","volume":"21","author":"Dandona","year":"2007","journal-title":"J Human Hypertension"},{"key":"10.1016\/j.mehy.2020.110394_b0270","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/hr.2009.74","article-title":"Devil and agel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1\u20137)-Mas receptor axis","volume":"32","author":"Iwai","year":"2009","journal-title":"Hypertens Res"},{"key":"10.1016\/j.mehy.2020.110394_b0275","doi-asserted-by":"crossref","first-page":"L17","DOI":"10.1152\/ajplung.00498.2016","article-title":"Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg(9) bradykinin\/BKB1R axis and facilitates LPS-induced neutrophil infiltration","volume":"314","author":"Sodhi","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.mehy.2020.110394_b0280","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fcimb.2020.00317","article-title":"ACE2, much more than just a receptor for SARS-CoV-2","volume":"10","author":"Samavati","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.mehy.2020.110394_b0285","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","article-title":"Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic","volume":"75","author":"Driggin","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mehy.2020.110394_b0290","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202005-1583OC","article-title":"Characterization of the Inflammatory Response to Severe COVID-19 Illness","author":"McElvaney","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mehy.2020.110394_b0295","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2353\/ajpath.2010.090793","article-title":"Neutrophil Elastase Contributes to Acute Lung Injury Induced by Bilateral Nephrectomy","volume":"177","author":"Ishii","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.mehy.2020.110394_b0300","doi-asserted-by":"crossref","first-page":"24067","DOI":"10.1074\/jbc.M115.659029","article-title":"Neutrophil Elastase Promotes Interleukin-1\u03b2 Secretion from Human Coronary Endothelium","volume":"290","author":"Alfaidi","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2020.110394_b0305","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/01902148.2019.1642968","article-title":"Alpha 1-antitrypsin for treating ventilator-associated lung injury in acute respiratory distress syndrome rats","volume":"45","author":"Wang","year":"2019","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.mehy.2020.110394_b0310","doi-asserted-by":"crossref","unstructured":"Mehraban S, Gu G, Ma S, Liu X, Turino G, Cantor J. The proinflammatory activity of structurally altered elastic fibers. Am J Respir Cell Mol Biol 2020; Online ahead of print.","DOI":"10.1165\/rcmb.2020-0064OC"},{"key":"10.1016\/j.mehy.2020.110394_b0315","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.chest.2017.03.056","article-title":"The Role of Neutrophil Elastase Inhibitors in Lung Diseases","volume":"152","author":"Polverino","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.mehy.2020.110394_b0320","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nm0598-615","article-title":"Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis","volume":"4","author":"Belaaouaj","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2020.110394_b0325","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.59177","article-title":"A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm","volume":"9","author":"Garvin","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.mehy.2020.110394_b0330","doi-asserted-by":"crossref","unstructured":"Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med 2020; Online ahead of print.","DOI":"10.1056\/NEJMoa2015432"},{"key":"10.1016\/j.mehy.2020.110394_b0335","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/rth2.12400","article-title":"Thrombosis and coagulopathy in COVID-19: An illustrated review","volume":"4","author":"Levi","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.mehy.2020.110394_b0340","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0009-8981(67)90104-0","article-title":"\u03b11-antitrypsin, an inhibitor for thrombin and plasmin","volume":"17","author":"Gans","year":"1967","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.mehy.2020.110394_b0345","doi-asserted-by":"crossref","first-page":"829","DOI":"10.4330\/wjc.v7.i12.829","article-title":"Do neutrophil extracellular traps contribute to the heightened risk of thrombosis in inflammatory diseases?","volume":"7","author":"Rao","year":"2015","journal-title":"World J Cardiol"},{"key":"10.1016\/j.mehy.2020.110394_b0350","article-title":"Neutrophil extracellular traps in COVID-19","volume":"5","author":"Zuo","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.mehy.2020.110394_b0355","doi-asserted-by":"crossref","unstructured":"Zuo Y, Yalavarthi S, Shi H, et al. Neutrophil extracellular traps (NETs) as markers of disease severity in COVID-19. medRxiv 2020; 2020: Pre-print.","DOI":"10.1101\/2020.04.09.20059626"},{"key":"10.1016\/j.mehy.2020.110394_b0360","doi-asserted-by":"crossref","unstructured":"Zuo Y, Zuo M, Yalavarthi S, et al. Neutrophil extracellular traps and thrombosis in COVID-19. medRxiv 2020; 2020: Pre-print.","DOI":"10.1101\/2020.04.30.20086736"},{"key":"10.1016\/j.mehy.2020.110394_b0365","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200652","article-title":"Targeting potential drivers of COVID-19: Neutrophil extracellular traps","volume":"217","author":"Barnes","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2020.110394_b0370","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1083\/jcb.201006052","article-title":"Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps","volume":"191","author":"Papayannopoulos","year":"2010","journal-title":"J Cell Biol"},{"key":"10.1016\/j.mehy.2020.110394_b0375","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.7150\/ijbs.4701","article-title":"Does augmentation with alpha1-antitrypsin affect neutrophil extracellular traps formation?","volume":"8","author":"Frenzel","year":"2012","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.mehy.2020.110394_b0380","doi-asserted-by":"crossref","unstructured":"Kayem G, Lecarpentier E, Deruelle P, et al. A snapshot of the Covid-19 pandemic among pregnant women in France. J Gynecol Obstet Hum Reprod 2020; Online ahead of print.","DOI":"10.1016\/j.jogoh.2020.101826"},{"key":"10.1016\/j.mehy.2020.110394_b0385","doi-asserted-by":"crossref","unstructured":"Mendoza M, Garcia-Ruiz I, Maiz N, et al. Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study. BJOG 2020; Online ahead of print.","DOI":"10.1111\/1471-0528.16339"},{"key":"10.1016\/j.mehy.2020.110394_b0390","article-title":"Pre-eclampsia: pathophysiology and clinical implications","volume":"366","author":"Burton","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.mehy.2020.110394_b0395","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1055\/s-0038-1675788","article-title":"Increased Neutrophil Activation and Plasma DNA Levels in Patients with Pre-Eclampsia","volume":"118","author":"Hu","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.mehy.2020.110394_b0400","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"D\u2019uvekot JJ, Pijnenborg R. Pre-eclampsia","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.110394_b0405","doi-asserted-by":"crossref","unstructured":"Zuo Y, Estes SK, Gandhi AA, et al. Prothrombotic antiphospholipid antibodies in COVID-19. medRxiv 2020; pre-print.","DOI":"10.1101\/2020.06.15.20131607"},{"key":"10.1016\/j.mehy.2020.110394_b0410","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1164\/rccm.200512-1842OC","article-title":"A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema","volume":"173","author":"Petrache","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mehy.2020.110394_b0415","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2353\/ajpath.2006.060058","article-title":"Alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis","volume":"169","author":"Petrache","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.mehy.2020.110394_b0420","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.3109\/14767058.2012.705397","article-title":"Lower circulation levels and activity of \u03b1-1 antitrypsin in pregnant women with severe preeclampsia","volume":"25","author":"Twina","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.mehy.2020.110394_b0425","doi-asserted-by":"crossref","first-page":"113002","DOI":"10.18632\/oncotarget.22949","article-title":"Alpha-1-antitrypsin functions as a protective factor in preeclampsia through activating Smad2 and inhibitor of DNA binding 4","volume":"8","author":"Feng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.mehy.2020.110394_b0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173711","article-title":"Alpha-1-antitrypsin suppresses oxidative stress in preeclampsia by inhibiting the p38MAPK signaling pathway: An in vivo and in vitro study","volume":"12","author":"Feng","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2020.110394_b0435","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/15412555.2020.1754778","article-title":"Alpha-1 Antitrypsin Deficiency and Pregnancy","volume":"17","author":"Gaeckle","year":"2020","journal-title":"COPD"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720332850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720332850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:24:22Z","timestamp":1759692262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720332850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":87,"alternative-id":["S0306987720332850"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110394","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110394"}}